Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
A performance improvement project to increase appropriate reporting of weekly paclitaxel infusion related hypersensitivity adverse drug reactions at a major tertiary cancer center.
- At: Basel (Switzerland) (2008)
- Type: Poster
- By: LAL, Lincy (University of Texas - MD Anderson Cancer Center, Houston, United States of America)
- Co-author(s): Dana, William (University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America)
Gerber, Donna (University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America) - Abstract:
Objectives: This prospective performance improvement project identifies, intervenes, and measures the impact of a clinical safety and effectiveness program to increase and improve the rate of appropriate reporting of weekly paclitaxel infusion related hypersensitivity reactions in an electronic medical record (EMR) system at a major tertiary..
The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 4 October 2019